A new study of Alcohol-abuse Drug Antabuse is effective against cancer cells. The study has researched by an international team including researchers from Karolinska Institutet. The study also identifies a potential mechanism of action for ...
Cancer researchers at the University of Bergen (UiB) in Norway have been experimenting with hundreds of known drugs in recent years to see how they influence cancer cells of Prostate Cancer. Their most recent discovery shows that a medic ...
Preclinical Cancer Drug Discoveries Researchers from the Gladstone Institutes have discovered that newly-developed cancer drugs may also provide a treatment option for heart failure patients. Heart failure is the leading cause of mortality, hospi ...
In experiments with human colon cancer cells and mice, a team led by scientists at the Johns Hopkins Kimmel Cancer Center say they have evidence that cancer origins when a normal part of cells’ machinery generally used to repair DNA damage is diverte ...
Paris-based Nanobiotix is a late clinical-stage nanomedicine company that is spearheading efforts to harness physics rather than biology, as a way to destroy cancer cells. Founded in 2003 by CEO Laurent Levy, Ph.D., as a spin-off the State Universit ...
A research team from the United States and Canada has developed and successfully tested new computational software that determines whether a human DNA sample, through DNA analysis, includes an epigenetic add-on linked to can ...
A man with deadly brain cancer that had spread to his spine saw his tumors shrink and, for a time, completely vanish after a novel treatment to help his immune system attack his disease - another first in this promising field. The type of immunother ...
The market size for cancer immunotherapies is expected to grow more than fourfold from $16.9 billion in 2015 to $75.8 billion by 2022, representing a rapid compound annual growth rate (CAGR) of 23.9%, according to business intelligence provider GBI R ...
Immunologists at St. Jude Children's Research Hospital have discovered that a protein called NLRC3 plays a central role in inhibiting colon cells from becoming cancerous. The study, led by Thirumala-Devi Kanneganti, Ph.D., a mem ...
Breast cancer mortality rates continue to decline in many nations, but a review of mortality trends in 47 countries around the world indicates some significant disparities, particularly in South Korea and some Latin American nations, according to res ...